An epitope-specific chemically defined nanoparticle vaccine for respiratory syncytial virus

Abstract Respiratory syncytial virus (RSV) can cause severe respiratory disease in humans, particularly in infants and the elderly. However, attempts to develop a safe and effective vaccine have so far been unsuccessful. Atomic-level structures of epitopes targeted by RSV-neutralizing antibodies are...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Armando Zuniga, Oliver Rassek, Melissa Vrohlings, Aniebrys Marrero-Nodarse, Kerstin Moehle, John A. Robinson, Arin Ghasparian
Format: article
Langue:EN
Publié: Nature Portfolio 2021
Sujets:
Accès en ligne:https://doaj.org/article/adb559966dc64ff4b26148413e229c01
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!